ArticleNature plants2026
N-glycosylation code diversifies paralogous chitinases to balance plant immunity and growth.
Article in Nature plants, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Balancing immunity and growth is a fundamental challenge for plants. Surprisingly, fungal cell-wall chitin elicits robust immune responses without causing growth inhibition, yet constitutive intracellular chitin signalling severely impairs growth. How plants resolve this paradox remains unclear. Here we identify two chitin-inducible, paralogous apoplastic chitinases in Arabidopsis thaliana, MIC1 and MIC2, both possessing direct antifungal activity through chitin hydrolysis. MIC2 generates immunogenic chitin oligomers that activate chitin-triggered immunity, whereas MIC1 ultimately degrades chitin into non-immunogenic dimers and monomers, thereby dampening growth-inhibitory signalling. This functional divergence is dictated by Asn137 glycosylation in MIC1. Removing this N-glycan converts MIC1 into a MIC2-like enzyme. MIC1-like chitinases are widespread in plants, and Oryza sativa Osmic1 mutants exhibit enhanced fungal resistance without growth defects. Our work defines an N-glycosylation code that governs the functional specialization of paralogous chitinases and provides a conserved molecular target for breeding crops with improved fungal resistance and uncompromised growth.
Identifiers
42834127What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.